We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.33%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,055

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCG icon
3051
First Trust Natural Gas ETF
FCG
$645M
-12,500
Closed -$286K
FDUS icon
3052
Fidus Investment
FDUS
$753M
-10,797
Closed -$186K
FEAM icon
3053
5E Advanced Materials
FEAM
$81.4M
-648
Closed -$151K
FFIV icon
3054
F5
FFIV
$23.2B
-142,363
Closed -$20.6M
FHI icon
3055
Federated Hermes
FHI
$4.71B
-13,300
Closed -$441K
FLGB icon
3056
Franklin FTSE United Kingdom ETF
FLGB
$930M
-52,068
Closed -$1.02M
FLIC
3057
DELISTED
First of Long Island Corp
FLIC
-24,967
Closed -$431K
FLNC icon
3058
Fluence Energy
FLNC
$2.34B
-34,624
Closed -$507K
FLO icon
3059
Flowers Foods
FLO
$1.51B
-69,525
Closed -$1.72M
FMNB icon
3060
Farmers National Banc Corp
FMNB
$931M
-27,616
Closed -$361K
FMX icon
3061
Fomento Económico Mexicano
FMX
$40.9B
-198,074
Closed -$12.4M
FMS icon
3062
Fresenius Medical Care
FMS
$13B
-311,743
Closed -$4.38M
FPAY
3063
DELISTED
FlexShopper
FPAY
-154,517
Closed -$287K
FSLR icon
3064
First Solar
FSLR
$25.7B
-322,722
Closed -$42.7M
FSLY icon
3065
Fastly Inc
FSLY
$4.42B
-358,023
Closed -$3.28M
FSM icon
3066
Fortuna Silver Mines
FSM
$3.18B
-396,027
Closed -$998K
FTDR icon
3067
Frontdoor
FTDR
$5.78B
-65,619
Closed -$1.34M
FTEC icon
3068
Fidelity MSCI Information Technology Index ETF
FTEC
$21.1B
-10,500
Closed -$954K
FUL icon
3069
H.B. Fuller
FUL
$3.29B
-11,669
Closed -$701K
FWONK icon
3070
Liberty Media Series C
FWONK
$25.8B
-93,352
Closed -$5.28M
FXY icon
3071
CALL
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
-7,300
Closed -$472K
GB.WS
3072
CALL
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
-199,690
Closed -$924K
GCT icon
3073
GigaCloud Technology
GCT
$1.84B
-140,721
Closed -$1.43M
GDOT icon
3074
Green Dot
GDOT
$752M
-132,267
Closed -$2.51M
GE icon
3075
PUT
GE Aerospace
GE
$380B
-18,138
Closed -$699K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,055 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,055 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.